All News

Regeneron and Sanofi will amend their ongoing trial of sarilumab (Kevzara) to enroll only “critical” hospitalized patients with COVID-19.

Depending on the situation, individuals with IBD who develop COVID-19 may want to alter their medication.

The Compounders’ Shortage Drug Source for Hospitals is now accepting shortage drug preparation information from outsourcing facilities and approved 503A compounding pharmacies.

The FDA warned against the use of hydroxychloroquine and chloroquine outside of the hospital setting or clinical trials due to safety risks. 

Here's the roundup of the latest coronavirus-related news.

To date, 19 states have authorized pharmacists to order and conduct testing for COVID-19.

The study estimates that for each child in the PICU for COVID-19, another 2381 children are infected with the virus.

In part 2 of our video interview, Doug Hackenyos, oncology pharmacy clinical coordinator at the University of Connecticut, discusses the effects of COVID-19 on cancer care pharmacy.

Two new studies underscore health disparities in rural United States affecting mortality rates associated with cardiovascular disease.

Officials with the FDA have granted accelerated approval to sacituzumab govitecan-hziy (Trodelvy, Immunomedics Inc.) for previously-treated adult patients with metastatic triple-negative breast cancer.

Siponimod (Mayzent, Novartis) had a sustained effect on slowing disability progression in patients with secondary progressive multiple sclerosis (SPMS), according to new long-term data from a phase 3 study.

The study found that genetic variability across HLA A, B, and C could affect susceptibility to and severity of COVID-19.

If health care were a country, it would be the fifth largest emitter of greenhouse gases worldwide.

This is the first diagnostic test authorized by the FDA with a home collection option for COVID-19.

The guidelines provide clinical recommendations to providers treating patients with coronavirus disease 2019 (COVID-19).

"With the introduction of this ibrutinib-rituximab combination, patients now have a more effective, non-chemoimmunotherapy option."

“The reality is that pharmacy workers are smack dab in the middle of trauma.”

Early treatment of shingles reduces symptoms and risk of serious complications.

Eighty-eight percent of community pharmacy owners reported intentions to apply for COVID-19 federal aid, such as provisions from the CARES Act, according to the survey

The study examined the effects of unprotected, prolonged patient contact, along with certain exposures, on the risk of health care providers becoming infected with COVID-19.

Pharmacist reminders boost shingles vaccination compliance.

Genentech is seeking approval for a 2-hour ocrelizumab (Ocrevus) infusion time in patients with relapsing or primary progressive multiple sclerosis.

Officials with the FDA today approved tucatinib (Tukysa, Seattle Genetics) in combination with chemotherapy trastuzumab and capecitabine for the treatment of adults with advanced forms of HER2-positive breast cancer.

Here's a roundup of the latest coronavirus-related news.

Investigators used simulation models to project the transmission dynamics of COVID-19.

President Donald J. Trump announced his proposed plan for reopening US state economies amidst the coronavirus disease 2019 (COVID-19) pandemic, with steps outlined in a 3-phase approach.